AlphaFold predicted structure
DBT · P11182

Mean pLDDT
78.9/ 100
Confident
482 residues
Confidence breakdown
- Very high(≥ 90)55%
- Confident(70–90)19%
- Low(50–70)5%
- Very low(< 50)21%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dihydrolipoamide branched chain transacylase E2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalmaple syrup urine disease
maple syrup urine disease type 1A
maple syrup urine disease type 2
intermediate maple syrup urine disease
intermittent maple syrup urine disease
convulsion
Seizure
thiamine-responsive maple syrup urine disease
classic maple syrup urine disease
hereditary disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial
The branched-chain alpha-keto dehydrogenase complex catalyzes the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It contains multiple copies of three enzymatic components: branched-chain alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3). Within this complex, the catalytic function of this enzyme is to accept, and to transfer to coenzyme A, acyl groups that are generated by the branched-chain alpha-keto acid decarboxylase component
DBT · P11182

Mean pLDDT
78.9/ 100
Confident
482 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0